Literature DB >> 22623800

Human T-cell leukemia virus type 2 antisense viral protein 2 is dispensable for in vitro immortalization but functions to repress early virus replication in vivo.

Han Yin1, Priya Kannian, Nathan Dissinger, Robyn Haines, Stefan Niewiesk, Patrick L Green.   

Abstract

Human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 are closely related but pathogenically distinct human retroviruses. The antisense strand of the HTLV-1 genome encodes HTLV-1 basic leucine zipper (b-ZIP) protein (HBZ), a protein that inhibits Tax-mediated viral transcription, enhances T-cell proliferation, and promotes viral persistence. Recently, an HTLV-2 antisense viral protein (APH-2) was identified. Despite its lack of a typical b-ZIP domain, APH-2, like HBZ, interacts with cyclic AMP response element binding protein (CREB) and downregulates Tax-mediated viral transcription. Here, we provide evidence that the APH-2 C-terminal LXXLL motif is important for CREB binding and Tax repression. In order to investigate the functional role of APH-2 in the HTLV-2-mediated immortalization of primary T lymphocytes in vitro and in HTLV-2 infection in vivo, we generated APH-2 mutant viruses. In cell cultures, the immortalization capacities of APH-2 mutant viruses were indistinguishable from that of wild-type HTLV-2 (wtHTLV-2), indicating that, like HBZ, APH-2 is dispensable for viral infection and cellular transformation. In vivo, rabbits inoculated with either wtHTLV-2 or APH-2 mutant viruses established a persistent infection. However, the APH-2 knockout virus displayed an increased replication rate, as measured by an increased viral antibody response and a higher proviral load. In contrast to HTLV-1 HBZ, we show that APH-2 is dispensable for the establishment of an efficient infection and persistence in a rabbit animal model. Therefore, antisense proteins of HTLV-1 and HTLV-2 have evolved different functions in vivo, and further comparative studies will provide fundamental insights into the distinct pathobiologies of these two viruses.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22623800      PMCID: PMC3421770          DOI: 10.1128/JVI.00717-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

1.  HTLV-2 APH-2 expression is correlated with proviral load but APH-2 does not promote lymphocytosis.

Authors:  Estelle Douceron; Zhanna Kaidarova; Paola Miyazato; Masao Matsuoka; Edward L Murphy; Renaud Mahieux
Journal:  J Infect Dis       Date:  2011-11-07       Impact factor: 5.226

2.  The pX protein of HTLV-I is a transcriptional activator of its long terminal repeats.

Authors:  B K Felber; H Paskalis; C Kleinman-Ewing; F Wong-Staal; G N Pavlakis
Journal:  Science       Date:  1985-08-16       Impact factor: 47.728

3.  HTLV-I and HTLV-II Tax: differences in induction of micronuclei in cells and transcriptional activation of viral LTRs.

Authors:  O J Semmes; F Majone; C Cantemir; L Turchetto; B Hjelle; K T Jeang
Journal:  Virology       Date:  1996-03-01       Impact factor: 3.616

4.  The tax gene of human T-cell leukemia virus type 2 is essential for transformation of human T lymphocytes.

Authors:  T M Ross; S M Pettiford; P L Green
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

5.  Immortalization of CD4(+) and CD8(+) T lymphocytes by human T-cell leukemia virus type 1 Tax mutants expressed in a functional molecular clone.

Authors:  M D Robek; L Ratner
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

6.  Human T-cell leukemia virus type-1 antisense-encoded gene, Hbz, promotes T-lymphocyte proliferation.

Authors:  Joshua Arnold; Bevin Zimmerman; Min Li; Michael D Lairmore; Patrick L Green
Journal:  Blood       Date:  2008-08-08       Impact factor: 22.113

Review 7.  Human T-lymphotropic virus type II and neurological disease.

Authors:  Abelardo Araujo; William W Hall
Journal:  Ann Neurol       Date:  2004-07       Impact factor: 10.422

8.  HBZ interacts with JunD and stimulates its transcriptional activity.

Authors:  Sabine Thébault; Jihane Basbous; Patrick Hivin; Christian Devaux; Jean-Michel Mesnard
Journal:  FEBS Lett       Date:  2004-03-26       Impact factor: 4.124

9.  Human T Lymphotropic Virus Type 1 (HTLV-1): Molecular Biology and Oncogenesis.

Authors:  Priya Kannian; Patrick L Green
Journal:  Viruses       Date:  2010-09-24       Impact factor: 5.818

10.  HTLV-1 HBZ cooperates with JunD to enhance transcription of the human telomerase reverse transcriptase gene (hTERT).

Authors:  Anne-Sophie Kuhlmann; Julien Villaudy; Louis Gazzolo; Marc Castellazzi; Jean-Michel Mesnard; Madeleine Duc Dodon
Journal:  Retrovirology       Date:  2007-12-13       Impact factor: 4.602

View more
  22 in total

1.  Stability of HTLV-2 antisense protein is controlled by PML nuclear bodies in a SUMO-dependent manner.

Authors:  Louise Dubuisson; Florence Lormières; Stefania Fochi; Jocelyn Turpin; Amandine Pasquier; Estelle Douceron; Anaïs Oliva; Ali Bazarbachi; Valérie Lallemand-Breitenbach; Hugues De Thé; Chloé Journo; Renaud Mahieux
Journal:  Oncogene       Date:  2018-03-06       Impact factor: 9.867

2.  The ESCRT-0 Protein HRS Interacts with the Human T Cell Leukemia Virus Type 2 Antisense Protein APH-2 and Suppresses Viral Replication.

Authors:  Fanny Martini; Coline Arone; Amy Hasset; William W Hall; Noreen Sheehy
Journal:  J Virol       Date:  2019-12-12       Impact factor: 5.103

3.  Role of Wild-type and Recombinant Human T-cell Leukemia Viruses in Lymphoproliferative Disease in Humanized NSG Mice.

Authors:  Devra D Huey; Brad Bolon; Krista M D La Perle; Priya Kannian; Steven Jacobson; Lee Ratner; Patrick L Green; Stefan Niewiesk
Journal:  Comp Med       Date:  2018-02-01       Impact factor: 0.982

4.  Human T-cell leukemia virus type 3 (HTLV-3) and HTLV-4 antisense-transcript-encoded proteins interact and transactivate Jun family-dependent transcription via their atypical bZIP motif.

Authors:  Émilie Larocque; Charlotte André-Arpin; Malgorzata Borowiak; Guy Lemay; William M Switzer; Madeleine Duc Dodon; Jean-Michel Mesnard; Benoit Barbeau
Journal:  J Virol       Date:  2014-05-28       Impact factor: 5.103

5.  Novel interactions between the HTLV antisense proteins HBZ and APH-2 and the NFAR protein family: Implications for the HTLV lifecycles.

Authors:  Jane Murphy; William W Hall; Lee Ratner; Noreen Sheehy
Journal:  Virology       Date:  2016-04-22       Impact factor: 3.616

6.  Functional Comparison of HBZ and the Related APH-2 Protein Provides Insight into Human T-Cell Leukemia Virus Type 1 Pathogenesis.

Authors:  Amanda R Panfil; Nathan J Dissinger; Cory M Howard; Brandon M Murphy; Kristina Landes; Soledad A Fernandez; Patrick L Green
Journal:  J Virol       Date:  2016-01-27       Impact factor: 5.103

7.  Human T lymphotropic virus type 1 SU residue 195 plays a role in determining the preferential CD4+ T cell immortalization/transformation tropism.

Authors:  Priya Kannian; Soledad Fernandez; Kathryn S Jones; Patrick L Green
Journal:  J Virol       Date:  2013-06-19       Impact factor: 5.103

Review 8.  HTLV-1 and HTLV-2: highly similar viruses with distinct oncogenic properties.

Authors:  Vincenzo Ciminale; Francesca Rende; Umberto Bertazzoni; Maria G Romanelli
Journal:  Front Microbiol       Date:  2014-07-29       Impact factor: 5.640

9.  Interplay between the HTLV-2 Tax and APH-2 proteins in the regulation of the AP-1 pathway.

Authors:  Céline Marban; Aine McCabe; Terence N Bukong; William W Hall; Noreen Sheehy
Journal:  Retrovirology       Date:  2012-12-03       Impact factor: 4.602

10.  Functional comparison of antisense proteins of HTLV-1 and HTLV-2 in viral pathogenesis.

Authors:  Benoit Barbeau; Jean-Marie Peloponese; Jean-Michel Mesnard
Journal:  Front Microbiol       Date:  2013-08-07       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.